Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep Neuromuscular Blockade in Laparoscopic Colorectal Surgery
NCT03910998Phase 4Unknown
- Start
- May 2019
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of rocuronium. Primary endpoint: Total intra-operative remifentanil consumption. Status: unknown.
02
Drugs
rocuronium
Beyond the preview
Go deeper on NCT03910998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03910998.